Seroconversion after anti‐SARS‐CoV‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals—Prospective observational cohort study

It is unclear whether biological antipsoriatic therapies affect seroconversion after messenger ribonucleic acid (mRNA)‐based antisevere acute respiratory syndrome coronavirus 2 (anti‐SARS‐CoV‐2) vaccinations. To assess antibody formation and the incidence of side effects after anti‐SARS‐CoV‐2 mRNA v...

Descripción completa

Detalles Bibliográficos
Autores principales: Piros, Éva Anna, Cseprekál, Orsolya, Görög, Anna, Hidvégi, Bernadett, Medvecz, Márta, Szabó, Zsófia, Olajos, Ferenc, Barabás, Eszter, Galajda, Noémi, Miheller, Pál, Holló, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111760/
https://www.ncbi.nlm.nih.gov/pubmed/35218276
http://dx.doi.org/10.1111/dth.15408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111760/
https://www.ncbi.nlm.nih.gov/pubmed/35218276
http://dx.doi.org/10.1111/dth.15408

Ejemplares similares